Skip to content

The Effects of Pacifier Activated Lullaby in VLBW Preterm Infants

The Effects of Pacifier Activated Lullaby in VLBW Preterm Infants: an Italian Randomized Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04337476
Acronym
PAL
Enrollment
40
Registered
2020-04-07
Start date
2020-04-30
Completion date
2021-12-01
Last updated
2022-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Music Therapy

Keywords

Music therapy, Preterm, PAL, HRV, Parental voice

Brief summary

Music and music therapy, live or recorded, has been introduced in the Neonatal Intensive Care Unit (NICU) of the Del Ponte hospital in Varese in addition to standard medical and nursing care, to improve premature neonates' neurophysiological development. Recent studies focused on the effects of the maternal voice or the entrained singing and live music, highlighting their benefits on neonates stress, on not-nutritive sucking and on the caloric intake. Aim of our study is to evaluate the effect of parents singing or musictherapist singing admistered by Pacifier Activated Lullaby (PAL) on infant's behavior and nutritional outcomes. Particularly, we will evaluate infants' Heart Rate Variability during music therapy session, exclusive oral feeding achievement, weigth increase and hospitalization in a group of preterm infants administered to PAL compared with a control group of preterm infants not exposed to PAL stimulus.

Detailed description

A Prospective randomized controlled pilot study trial will be conducted. Infants will be evaluated at 32-34 post-conceptional weeks when the volume of milk assumed orally will be less than 50% of the total enteral intake. Infants with gestational age less than 34 weeks will be enrolled. After the request for informed consent, participants will be randomized randomly through computerized. The administration of the PAL and the reproduction of the relative voices will be performed by the music therapist. Objective of this study is to evaluate the tolerance (in terms of clinical stability, described through the HRV parameter) of the PAL device by the enrolled customers and investigate any benefits of the positive reinforcement purchased, through its use, on the acquisition of food skills and on the growth of preterms. Primary Outcome: Clinical Stability Using Heart Rate Variability (HRV) Measurement during the music therapy treatment. Secondary Outcomes: effects of positive reinforcement (obtained through the use of the device PAL) on the acquisition of food skills and the growth of preterm consumers. In particular: * Evaluation of the achievement of the exclusive oral sucking * Evaluation of the variation in the rate of meal intake between the beginning and the end of the intervention * Assessment of the infant's weight gain in the 24 hours following stimulation * Evaluation of the rate of growth from the last day of treatment to discharge. * Duration of hospital stay.

Interventions

DEVICEThe effects of Pacifier Activated Lullaby in very low birth weigt preterm infants. An italian music therapy intervention

Positive reinforcement is an effective development strategy for improving the feeding skills of preterm infants. A brief intervention with the PAL device with pacifier that reproduces lullabies sung by both parents or by the music therapist could reduce the use of the feeding tube and the length of hospital stay in preterm infants. The aim of this study is not only to evaluate the benefits of positive reinforcement on the nutritional sucking competence of the premature baby, but at the same time to observe its possible effects on its well-being and its clinical stability.

Sponsors

Ospedale di Circolo - Fondazione Macchi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Investigator)

Masking description

After acquiring informed consent, participants will be randomized randomly through computerized, block randomization by intervention group or group of control, which will assign a specific group to the newborns (mom voice, dad voice, music therapist voice or no voice). The clinical team and parents will be blind to the study group and will not know when the recordings will be reproduced. The administration of the PAL and the reproduction of the relative voices will be performed by the music therapist.

Intervention model description

Prospective randomized controlled trial, divided into four parallel groups of preterm infants

Eligibility

Sex/Gender
ALL
Age
23 Weeks to 34 Weeks
Healthy volunteers
No

Inclusion criteria

* gestational age between the 23th and the 34th week, sufficient stability of the vital parameters and absence of active infections and episodes of apnoea during the 72 hours before the test

Exclusion criteria

* Chromosomal aberrations, congenital maxillofacial malformations, respiratory support at evaluation time Neonates with failed responses to bilateral hearing screening performed by Automated Auditory Brainstem Response testing will be subsequently excluded Infants will be evaluated at 32-34 post-conceptional weeks when the volume of milk assumed orally will be less than 50% of the total enteral intake

Design outcomes

Primary

MeasureTime frameDescription
Heart Rate Variabilitythrough study completion (from 5 minutes before the test to 5 minutes after the test ended)Heart Rate Variability (HRV) according to different music genres listening. An electrocardiogram is performed to evaluate HRV parameters during the test's administration

Secondary

MeasureTime frameDescription
Full oral feedingmore or less than 35 post conceptional weeksFull oral feeding (\> 150 ml/kg/day) achievement, expressed as post-conceptional weeks.
oral feeding velocitymore or less than 30 minutestime (expressed as minutes) necessary to consume oral feeding
weight gain24 hours after test% weight increase 24 hours after test administration
lenght of staymore or less than 36 post conceptional weekslength of hospitalization (expressed as post-conceptional weeks at discharge)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026